AM095 is primarily used in research settings to study its effects on the body's metabolism and energy regulation. It acts as a selective agonist for certain receptors involved in metabolic processes, making it valuable for investigating potential treatments for metabolic disorders such as obesity and type 2 diabetes. Researchers are particularly interested in its ability to modulate fat metabolism and improve insulin sensitivity. Additionally, AM095 has shown promise in preclinical studies for its role in reducing inflammation and fibrosis, which could have implications for treating conditions like non-alcoholic steatohepatitis (NASH). Its application in these areas is still under investigation, with ongoing studies aiming to better understand its therapeutic potential and safety profile.